Codexis to Present at the LD Micro Main Event VII Conference on December 4

REDWOOD CITY, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide a corporate update at the LD Micro Main Event VII Conference, being held December 2-4, 2014 at The Luxe Hotel in Los Angeles, California.

Codexis Presentation Details

Date: Thursday, December 4
Time: 12:30 p.m. Pacific Time
Location: Luxe Hotel, Los Angeles
Webcast: http://wsw.com/webcast/ldmicro7/cdxs

About Codexis, Inc.

Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. Codexis' proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.

CONTACT: Investors Andrew McDonald, 646-597-6987 Andrew@LifeSciAdvisors.com Media Kate Whelan, +46 72 216 98 49 Kate.whelan@notchcommunications.co.ukSource:Codexis